Trial Details
TERMINATEDBasic Information
| Clinical ID | c1124 |
|---|---|
| Identifier | NCT05542355 |
| Trial Title | EXL01 in the Maintenance of Steroid-induced Clinical Response/Remission in Participants With Mild to Moderate Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: EXL01|DRUG: Placebo|OTHER: SoC corticosteroid - Induction Period|OTHER: SoC corticosteroid - Tapering |
Participant Information
| Sponsor | Exeliom Biosciences |
|---|---|
| City | Liège |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2023-03-20 |
|---|---|
| Primary Completion Date | 2024-10-02 |
| Completion Date | 2024-10-02 |